Counterpoint Mutual Funds LLC raised its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 32.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,226 shares of the company's stock after buying an additional 2,250 shares during the quarter. Counterpoint Mutual Funds LLC's holdings in Cardinal Health were worth $1,091,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. State Street Corp increased its position in Cardinal Health by 4.6% during the third quarter. State Street Corp now owns 14,177,641 shares of the company's stock worth $1,566,913,000 after purchasing an additional 627,253 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock valued at $633,298,000 after buying an additional 42,082 shares during the period. Pacer Advisors Inc. increased its holdings in shares of Cardinal Health by 4.7% during the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company's stock worth $474,203,000 after buying an additional 191,568 shares during the last quarter. Amundi raised its position in shares of Cardinal Health by 5.5% during the 4th quarter. Amundi now owns 2,116,291 shares of the company's stock valued at $259,309,000 after buying an additional 110,605 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Cardinal Health by 3.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,519,011 shares of the company's stock valued at $179,653,000 after acquiring an additional 44,386 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several equities research analysts have issued reports on CAH shares. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and raised their target price for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Argus set a $148.00 price objective on shares of Cardinal Health in a report on Tuesday, February 4th. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. TD Cowen upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and lifted their price target for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Finally, Bank of America upgraded shares of Cardinal Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $139.36.
Get Our Latest Research Report on Cardinal Health
Cardinal Health Trading Down 1.0 %
NYSE:CAH traded down $1.29 during midday trading on Friday, reaching $131.80. The company had a trading volume of 5,709,521 shares, compared to its average volume of 1,975,897. The stock's fifty day simple moving average is $127.15 and its 200-day simple moving average is $119.87. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $133.77. The firm has a market capitalization of $31.84 billion, a price-to-earnings ratio of 24.59, a PEG ratio of 1.49 and a beta of 0.66.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.53%. Cardinal Health's payout ratio is currently 37.69%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.